Rahuldev Bhalla, MD, a fellowship-trained board-certified urologist, joined the combined medical group of RWJBarnabas Health and Rutgers Health, the systems said March 10. Dr. Bhalla will provide ...

Urologic oncologist Dr. Isaac Powell sits down with TODAY’s Al Roker to discuss his research into why Black men are more likely to be diagnosed with and die from prostate cancer. He talks about ...

For older men with low-risk prostate cancer, the urologist who diagnoses the disease could play a pivotal part in whether they are actively treated and, if so, the type of treatment they receive. "The ...

In January 2021, a movement to redefine low-risk Gleason 6 lesions as noncancers or precancers made its debut in this blog under the headline: "Is This Really Cancer?" Urologic oncologist Scott ...

Includes Late-Breaking Abstract on Results of Phase 3 BOND-003 Trial of Cretostimogene Monotherapy in High-Risk BCG-Unresponsive NMIBC and Four Trials in Progress Posters IRVINE, Calif., Nov. 20, 2024 ...

Cretostimogene is an investigational, intravesically delivered oncolytic immunotherapy that has been studied in a clinical development program, which includes more than 400 patients with Non-Muscle ...